Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
Holding RCKT?
Track your performance easily

Rocket Pharmaceuticals (RCKT) Financial Statements

1,183 Followers

Rocket Pharmaceuticals Financial Overview

Rocket Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.794; its P/E ratio is -6.15; Rocket Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit$ -800.00K$ -600.00K$ -700.00K$ -500.00K$ 400.00K
EBIT$ -69.17M$ -61.58M$ -61.43M$ -65.23M$ -59.77M
EBITDA$ -67.34M$ -59.87M-$ -64.03M$ -62.19M
Net Income Common Stockholders$ -69.65M$ -62.05M$ -61.90M$ -65.70M$ -58.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 278.82M$ 330.31M$ 437.17M$ 307.04M$ 331.08M
Total Assets$ 446.41M$ 499.44M$ 598.76M$ 461.78M$ 514.76M
Total Debt$ 25.80M$ 25.95M$ 25.18M$ 25.39M$ 25.40M
Net Debt$ -253.03M$ -304.36M$ -411.99M$ -281.65M$ -305.69M
Total Liabilities$ 61.78M$ 57.94M$ 57.68M$ 58.81M$ 55.88M
Stockholders Equity$ 384.63M$ 441.50M$ 541.09M$ 402.97M$ 458.88M
Cash Flow-
Free Cash Flow$ -55.75M$ -58.89M-$ -54.98M$ -60.61M
Operating Cash Flow$ -53.82M$ -56.86M$ -57.15M$ -50.86M$ -57.59M
Investing Cash Flow$ 55.62M$ 35.03M$ 48.25M$ 31.21M$ -36.72M
Financing Cash Flow$ 1.53M$ 1.18M$ 189.49M$ 182.00K$ 18.34M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

Rocket Pharmaceuticals Debt to Assets

Rocket Pharmaceuticals Cash Flow

Rocket Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis